Delivery Order SPE2DR25D1100-SPE2DR26FCV2E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,608.26 on December 11, 2025, for 100-count tablets of Envarsus XR 4 mg, with completion targeted for January 5, 2026. This competitively awarded, firm fixed-price delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Envarsus XR 1 mg tablets in a quantity of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,718.48 with firm fixed pricing and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,608.26 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units). This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by January 7, 2026, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Envarsus XR 1 mg tablets (100-count units) with a ceiling value of $1,718.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is expected to be completed by November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Envarsus XR 4 mg tablets (100 count) with a contract value of $5,412.39. This firm fixed-price delivery order, with an ultimate completion date of December 24, 2025, represents a non-set-aside, competitively awarded transaction under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Envarsus XR 1 mg tablets (30-count packages) with a ceiling value of $1,553.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,711.94 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets (100-count) on October 21, 2025, with completion targeted for November 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on March 12, 2025, for the supply of Envarsus XR 1 mg tablets (30-count packages) with a ceiling value of $3,883.50. This firm fixed-price delivery order, which must be completed by April 2, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Envarsus XR 1 mg tablets (100-count units) with a ceiling value of $1,811.00. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The order is scheduled for completion by January 9, 2026,...
- The Defense Logistics Agency awarded a $2,577.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Envarsus XR 1 mg tablets (100-unit quantity), with an ultimate completion date of October 7, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCV2EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Envarsus XR 1 mg tablets in a 30-count package, with a ceiling value of $1,637.04 and completion targeted for January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor contract running through December 2026. The contracting activity supports federal medical procurement needs across the military healthcare system and affiliated government agencies including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to federal customers. The company's SPE2DX vehicle functions as a comprehensive global pharmaceutical support mechanism enabling the delivery of diverse therapeutic products—including specialty medications, diabetes treatments, neurological drugs, and pain management pharmaceuticals—to support military healthcare programs worldwide. This delivery order for Envarsus XR, an immunosuppressant medication, exemplifies the company's ongoing role in fulfilling federal pharmaceutical supply requirements through flexible and competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/15/25 |